Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Bivigam (immune globulin intravenous)
- cholera vaccine, live
Interactions between your drugs
immune globulin intravenous cholera vaccine, live
Applies to: Bivigam (immune globulin intravenous), cholera vaccine, live
Immune globulin intravenous may interfere with your body's immune response to cholera vaccine, live. If you have been treated with immune globulin intravenous or received a blood product, your doctor may suggest you wait a certain period of time before being vaccinated with cholera vaccine, live. If you were vaccinated with cholera vaccine, live shortly before or after immune globulin intravenous, revaccination and/or laboratory testing for vaccine immunity may be necessary. The immunizing doctor should be informed of recent therapy with immune globulin intravenous or any blood product so that appropriate measures and/or precautions can be taken. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.
Drug and food interactions
cholera vaccine, live food
Applies to: cholera vaccine, live
Administration of cholera vaccine, live with food or drink may reduce its effectiveness. Avoid eating or drinking for 60 minutes before and after taking cholera vaccine, live.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Hizentra
Hizentra (immune globulin) is used as a replacement therapy in patients with primary humoral ...
Privigen
Privigen is used to treat primary immune deficiency conditions and idiopathic thrombocytopenic ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Gammagard Liquid
Gammagard (immune globulin) is used to treat primary immune deficiency and multifocal motor ...
Octagam
Octagam (immune globulin intravenous) is used to treat primary immunodeficiency diseases, immune ...
Xembify
Xembify (immune globulin subcutaneous) is used as a replacement therapy in patients with primary ...
Gamunex-C
Gamunex-C (immune globulin) is used to treat primary immunodeficiency, chronic inflammatory ...
Hyqvia
Hyqvia is used for chronic inflammatory demyelinating polyradiculoneuropathy, primary ...
Panzyga
Panzyga is used to treat primary humoral immunodeficiency (PI), chronic immune thrombocytopenia ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.